{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:51:46Z","timestamp":1791348706610,"version":"4.3.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL107953"],"award-info":[{"award-number":["R01HL107953"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL106063"],"award-info":[{"award-number":["R01HL106063"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1F31AG043318"],"award-info":[{"award-number":["1F31AG043318"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5F32DK103489-03"],"award-info":[{"award-number":["5F32DK103489-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.atherosclerosis.2016.01.025","type":"journal-article","created":{"date-parts":[[2016,1,18]],"date-time":"2016-01-18T17:30:30Z","timestamp":1453138230000},"page":"352-360","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["microRNAs in lipoprotein metabolism and cardiometabolic disorders"],"prefix":"10.1016","volume":"246","author":[{"given":"Noemi","family":"Rotllan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paramita","family":"Pati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leigh","family":"Goedeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fern\u00e1ndez-Hernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib1","series-title":"2015 Heart Disease and Stroke Statistics Update","author":"American Heart Association","year":"2015"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0092-8674(01)00238-0","article-title":"Atherosclerosis. The road ahead","volume":"104","author":"Glass","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib3","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1056\/NEJM197606172942509","article-title":"Familial hypercholesterolemia: a genetic defect in the low-density lipoprotein receptor","volume":"294","author":"Brown","year":"1976","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib4","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1161\/CIRCULATIONAHA.104.475715","article-title":"Macrophage reverse cholesterol transport: key to the regression of atherosclerosis?","volume":"113","author":"Cuchel","year":"2006","journal-title":"Circulation"},{"issue":"Suppl.\u00a0l","key":"10.1016\/j.atherosclerosis.2016.01.025_bib5","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1016\/0021-9150(94)05374-R","article-title":"Apolipoprotein A-I-containing particles and reverse cholesterol transport: evidence for connection between cholesterol efflux and atherosclerosis risk","volume":"110","author":"Fruchart","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.bbalip.2009.03.011","article-title":"The cell cholesterol exporter ABCA1 as a protector from cardiovascular disease and diabetes","volume":"1791","author":"Tang","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0022-2275(20)42221-7","article-title":"Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth","volume":"21","author":"Brown","year":"1980","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib8","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1161\/ATVBAHA.112.300144","article-title":"MicroRNAs in metabolic disease","volume":"33","author":"Fernandez-Hernando","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature02871","article-title":"The functions of animal microRNAs","volume":"431","author":"Ambros","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ng1536","article-title":"Combinatorial microRNA target predictions","volume":"37","author":"Krek","year":"2005","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.molcel.2007.06.017","article-title":"MicroRNA targeting specificity in mammals: determinants beyond seed pairing","volume":"27","author":"Grimson","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib14","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib15","doi-asserted-by":"crossref","first-page":"ra81","DOI":"10.1126\/scisignal.2000610","article-title":"Delivery of microRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection","volume":"2","author":"Zernecke","year":"2009","journal-title":"Sci. Signal"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib17","doi-asserted-by":"crossref","first-page":"5003","DOI":"10.1073\/pnas.1019055108","article-title":"Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma","volume":"108","author":"Arroyo","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/jcp.24486","article-title":"Microvesicle-shuttled miR-130b reduces fat deposition in recipient primary cultured porcine adipocytes by inhibiting PPAR-gamma expression","volume":"229","author":"Pan","year":"2014","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib19","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1007\/s00125-013-2996-8","article-title":"Circulating miR-130b mediates metabolic crosstalk between fat and muscle in overweight\/obesity","volume":"56","author":"Wang","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10408363.2014.937522","article-title":"Relevance of microRNA in metabolic diseases","volume":"51","author":"Price","year":"2014","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/11905","article-title":"Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency","volume":"22","author":"Brooks-Wilson","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib22","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/11914","article-title":"The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease","volume":"22","author":"Bodzioch","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib23","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1172\/JCI8119","article-title":"The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway","volume":"104","author":"Lawn","year":"1999","journal-title":"J.\u00a0Clin. investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib24","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/11921","article-title":"Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1","volume":"22","author":"Rust","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib25","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"de Aguiar Vallim","year":"2013","journal-title":"Cell. metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib26","doi-asserted-by":"crossref","first-page":"5641","DOI":"10.3748\/wjg.14.5641","article-title":"Physiology of bile secretion","volume":"14","author":"Esteller","year":"2008","journal-title":"World J. gastroenterol. WJG"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib27","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/hep.21950","article-title":"ATP8B1 requires an accessory protein for endoplasmic reticulum exit and plasma membrane lipid flippase activity","volume":"47","author":"Paulusma","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrm3313","article-title":"MicroRNAs in metabolism and metabolic disorders","volume":"13","author":"Rottiers","year":"2012","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib29","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1126\/science.1189862","article-title":"MiR-33 contributes to the regulation of cholesterol homeostasis","volume":"328","author":"Rayner","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib30","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1126\/science.1189123","article-title":"MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis","volume":"328","author":"Najafi-Shoushtari","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib31","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib32","doi-asserted-by":"crossref","first-page":"17321","DOI":"10.1073\/pnas.1008499107","article-title":"MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in\u00a0vivo","volume":"107","author":"Horie","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib33","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/MCB.00016-13","article-title":"MicroRNA 33 regulates glucose metabolism","volume":"33","author":"Ramirez","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib34","doi-asserted-by":"crossref","first-page":"12228","DOI":"10.1073\/pnas.1005191107","article-title":"miR-33 links SREBP-2 induction to repression of sterol transporters","volume":"107","author":"Marquart","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib35","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCRESAHA.117.305624","article-title":"Macrophage mitochondrial energy status regulates cholesterol efflux and is enhanced by anti-miR33 in atherosclerosis","volume":"117","author":"Karunakaran","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib36","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"miR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib37","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/hep.26427","article-title":"Regulation of cholesterol and bile acid homeostasis by the cholesterol 7alpha-hydroxylase\/steroid response element-binding protein 2\/microRNA-33a axis in mice","volume":"58","author":"Li","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib38","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1161\/ATVBAHA.113.301732","article-title":"Therapeutic silencing of microRNA-33 inhibits the progression of atherosclerosis in Ldlr-\/- mice\u2013brief report","volume":"33","author":"Rotllan","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib39","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib40","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib41","doi-asserted-by":"crossref","first-page":"e003376","DOI":"10.1161\/JAHA.112.003376","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE-\/- mice","volume":"1","author":"Horie","year":"2012","journal-title":"J.\u00a0Am. Heart Assoc."},{"issue":"212","key":"10.1016\/j.atherosclerosis.2016.01.025_bib42","doi-asserted-by":"crossref","first-page":"ra162","DOI":"10.1126\/scitranslmed.3006840","article-title":"Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR","volume":"5","author":"Rottiers","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib43","doi-asserted-by":"crossref","first-page":"5312","DOI":"10.1038\/srep05312","article-title":"MicroRNA-33b knock-in mice for an intron of sterol regulatory element-binding factor 1 (Srebf1) exhibit reduced HDL-C in\u00a0vivo","volume":"4","author":"Horie","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib44","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1172\/JCI57275","article-title":"Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis","volume":"121","author":"Rayner","year":"2011","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib45","article-title":"MicroRNA-33 deficiency reduces the progression of atherosclerotic plaque in ApoE\u2212\/\u2212 mice","volume":"1","author":"Horie","year":"2012","journal-title":"J.\u00a0Am. Heart Assoc."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib46","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/ATVBAHA.112.300639","article-title":"Anti-miR-33 therapy does not alter the progression of atherosclerosis in low-density lipoprotein receptor-deficient mice","volume":"33","author":"Marquart","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib47","first-page":"2015","article-title":"MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis","author":"Ouimet","year":"2015","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib48","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.15252\/emmm.201404046","article-title":"Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice","volume":"6","author":"Goedeke","year":"2014","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1161\/CIRCRESAHA.115.303100","article-title":"Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33","volume":"115","author":"Allen","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib50","doi-asserted-by":"crossref","first-page":"2883","DOI":"10.1038\/ncomms3883","article-title":"MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice","volume":"4","author":"Horie","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib51","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1161\/ATVBAHA.115.306404","article-title":"Therapeutic inhibition of miR-33 promotes fatty acid oxidation but does not Ameliorate metabolic dysfunction in diet-induced obesity","volume":"12","author":"Karunakaran","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib52","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1161\/ATVBAHA.111.232066","article-title":"MicroRNA-758 regulates cholesterol efflux through posttranscriptional repression of ATP-binding cassette transporter A1","volume":"31","author":"Ramirez","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib53","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1161\/CIRCRESAHA.112.300648","article-title":"MicroRNA-144 regulates hepatic ABCA1 and plasma HDL following activation of the nuclear receptor FXR","volume":"112","author":"de Aguiar Vallim","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib54","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1161\/CIRCRESAHA.112.300626","article-title":"Control of cholesterol metabolism and plasma HDL levels by miRNA-144","volume":"112","author":"Ramirez","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib55","doi-asserted-by":"crossref","first-page":"5270","DOI":"10.1128\/JVI.03022-12","article-title":"MicroRNA-27a regulates lipid metabolism and inhibits hepatitis C virus replication in human hepatoma cells","volume":"87","author":"Shirasaki","year":"2013","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib56","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.atherosclerosis.2014.02.008","article-title":"MicroRNA-27a\/b regulates cellular cholesterol efflux, influx and esterification\/hydrolysis in THP-1 macrophages","volume":"234","author":"Zhang","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib57","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.atherosclerosis.2015.09.033","article-title":"miR-27b inhibits LDLR and ABCA1 expression but does not influence plasma and hepatic lipid levels in mice","volume":"243","author":"Goedeke","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib58","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.febslet.2012.03.068","article-title":"MiR-26 controls LXR-dependent cholesterol efflux by targeting ABCA1 and ARL7","volume":"586","author":"Sun","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib59","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/nm.3949","article-title":"MicroRNA-148a regulates LDL receptor and ABCA1 expression to control circulating lipoprotein levels","volume":"21","author":"Goedeke","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.3980","article-title":"Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis","volume":"21","author":"Wagschal","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib61","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1161\/ATVBAHA.114.304878","article-title":"MicroRNA 302a is a novel modulator of cholesterol homeostasis and atherosclerosis","volume":"35","author":"Meiler","year":"2015","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib62","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1128\/MCB.01580-12","article-title":"MicroRNAs 185, 96, and 223 repress selective high-density lipoprotein cholesterol uptake through posttranscriptional inhibition","volume":"33","author":"Wang","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib63","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.112.266502","article-title":"Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b","volume":"111","author":"Wang","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib64","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/ncomms4292","article-title":"HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells","volume":"5","author":"Tabet","year":"2014","journal-title":"Nat. Commun."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib65","doi-asserted-by":"crossref","first-page":"14518","DOI":"10.1073\/pnas.1215767111","article-title":"MicroRNA-223 coordinates cholesterol homeostasis","volume":"111","author":"Vickers","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0092-8674(00)80213-5","article-title":"The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor","volume":"89","author":"Brown","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib67","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1172\/JCI0215593","article-title":"SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver","volume":"109","author":"Horton","year":"2002","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib68","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/00041433-199904000-00008","article-title":"Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis","volume":"10","author":"Horton","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib69","doi-asserted-by":"crossref","first-page":"32379","DOI":"10.1074\/jbc.R000017200","article-title":"Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action","volume":"275","author":"Osborne","year":"2000","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib70","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib71","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4161\/rna.1.2.1066","article-title":"miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1","volume":"1","author":"Chang","year":"2004","journal-title":"RNA Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib72","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in\u00a0vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib73","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1093\/nar\/gkm1113","article-title":"Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver","volume":"36","author":"Elmen","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib74","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J.\u00a0Clin. investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib75","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J.\u00a0Clin. investig."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib76","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in\u00a0vivo antisense targeting","volume":"3","author":"Esau","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib77","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1172\/JCI63539","article-title":"Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver","volume":"122","author":"Hsu","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib78","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib79","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib80","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.atherosclerosis.2015.08.023","article-title":"MicroRNA-27a decreases the level and efficiency of the LDL receptor and contributes to the dysregulation of cholesterol homeostasis","volume":"242","author":"Alvarez","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib81","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2013.06.010","article-title":"An SREBP-responsive microRNA operon contributes to a regulatory loop for intracellular lipid homeostasis","volume":"18","author":"Jeon","year":"2013","journal-title":"Cell Metab."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib82","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1194\/jlr.M041335","article-title":"Identification of miR-185 as a regulator of de novo cholesterol biosynthesis and low density lipoprotein uptake","volume":"55","author":"Yang","year":"2014","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib83","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2015.10.026","article-title":"microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator","volume":"243","author":"Jiang","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib84","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/ncb2210","article-title":"MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins","volume":"13","author":"Vickers","year":"2011","journal-title":"Nat. Cell. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib85","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/ATVBAHA.112.300741","article-title":"Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs","volume":"33","author":"Wagner","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib86","first-page":"483","article-title":"Statins: a new insight into their mechanisms of action and consequent pleiotropic effects","volume":"59","author":"Jasinska","year":"2007","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib87","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nrcardio.2011.2","article-title":"Pharmacological strategies for lowering LDL cholesterol: statins and beyond","volume":"8","author":"Brautbar","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib88","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/nm.3200","article-title":"MicroRNA-30c reduces hyperlipidemia and atherosclerosis in mice by decreasing lipid synthesis and lipoprotein secretion","volume":"19","author":"Soh","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib89","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib90","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrcardio.2010.200","article-title":"Novel HDL-directed pharmacotherapeutic strategies","volume":"8","author":"Degoma","year":"2011","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib91","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMoa1209026","article-title":"Treatment of HCV infection by targeting microRNA","volume":"368","author":"Janssen","year":"2013","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2016.01.025_bib92","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/CIRCRESAHA.110.227496","article-title":"The art of microRNA research","volume":"108","author":"van Rooij","year":"2011","journal-title":"Circ. Res."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915016300259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T22:06:24Z","timestamp":1654121184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915016300259"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":92,"alternative-id":["S0021915016300259"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.025","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"microRNAs in lipoprotein metabolism and cardiometabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}